![Phase II clinical development of new drugs [electronic resource]](https://libdoc.korea.ac.kr/dl_image/IMG/14/000000348781/INTROIMAGE/000000348781_01.JPG)
| 000 | 00000cam u2200205 a 4500 | |
| 001 | 000045993223 | |
| 005 | 20190808112935 | |
| 006 | m d | |
| 007 | cr | |
| 008 | 190806s2017 si a ob 000 0 eng d | |
| 020 | ▼a 9789811041921 | |
| 020 | ▼a 9789811041945 (eBook) | |
| 040 | ▼a 211009 ▼c 211009 ▼d 211009 | |
| 050 | 4 | ▼a RM301.27 |
| 082 | 0 4 | ▼a 615.580724 ▼2 23 |
| 084 | ▼a 615.580724 ▼2 DDCK | |
| 090 | ▼a 615.580724 | |
| 245 | 0 0 | ▼a Phase II clinical development of new drugs ▼h [electronic resource] / ▼c Naitee Ting ... [et al.]. |
| 260 | ▼a Singapore : ▼b Springer, ▼c c2017. | |
| 300 | ▼a 1 online resource (xvii, 241 p.) : ▼b ill. (some col.). | |
| 490 | 1 | ▼a ICSA book series in statistics, ▼x 2199-0980 |
| 500 | ▼a Title from e-Book title page. | |
| 504 | ▼a Includes bibliographical references. | |
| 505 | 0 | ▼a Chapter 1 Introduction -- Chapter 2 Concept of Alpha -- Chapter 3 Confirmation and Exploration -- Chapter 4 Design a Proof of Concept (PoC) Trial -- Chapter 5 Design of Dose-Ranging Trials -- Chapter 6 Combining PoC and Dose Ranging Trials -- Chapter 7 Risks of Inconclusiveness -- Chapter 8 Analysis of a PoC Study -- Chapter 9 Data Analysis for Dose-Ranging Trials with Continuous Outcome -- Chapter 10 Data Analysis of Dose-Ranging Trials for Binary Outcomes -- Chapter 11 Bayesian Methods -- Chapter 12 Overview of Phase III Clinical Trials. |
| 520 | ▼a This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them. | |
| 530 | ▼a Issued also as a book. | |
| 538 | ▼a Mode of access: World Wide Web. | |
| 650 | 0 | ▼a Drugs ▼x Testing. |
| 650 | 0 | ▼a Drug development. |
| 700 | 1 | ▼a Ting, Naitee. |
| 830 | 0 | ▼a ICSA book series in statistics. |
| 856 | 4 0 | ▼u https://oca.korea.ac.kr/link.n2s?url=https://doi.org/10.1007/978-981-10-4194-5 |
| 945 | ▼a KLPA | |
| 991 | ▼a E-Book(소장) |
소장정보
| No. | 소장처 | 청구기호 | 등록번호 | 도서상태 | 반납예정일 | 예약 | 서비스 |
|---|---|---|---|---|---|---|---|
| No. 1 | 소장처 중앙도서관/e-Book 컬렉션/ | 청구기호 CR 615.580724 | 등록번호 E14016429 | 도서상태 대출불가(열람가능) | 반납예정일 | 예약 | 서비스 |
컨텐츠정보
책소개
This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them.
New feature
This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them.정보제공 :
목차
Chapter 1 Introduction.- Chapter 2 Concept of Alpha.- Chapter 3 Confirmation and Exploration.- Chapter 4 Design a Proof of Concept (PoC) Trial.- Chapter 5 Design of Dose-Ranging Trials.- Chapter 6 Combining PoC and Dose Ranging Trials.- Chapter 7 Risks of Inconclusiveness.- Chapter 8 Analysis of a PoC Study.- Chapter 9 Data Analysis for Dose-Ranging Trials with Continuous Outcome.- Chapter 10 Data Analysis of Dose-Ranging Trials for Binary Outcomes.- Chapter 11 Bayesian Methods.- Chapter 12 Overview of Phase III Clinical Trials.
정보제공 :